Corona Remedies

{
  "main_header": {
    "sid": 10039887,
    "name": "Corona Remedies",
    "stock_name": "Corona Remedies",
    "full_name": "Corona Remedies Ltd",
    "name_url": "stocks-analysis/corona-remedies",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,728.40",
    "chg": 47.65,
    "chgp": "2.84%",
    "dir": 1,
    "prev_price": "1,680.75",
    "mcapval": "10,454.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544644,
    "symbol": "CORONA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE02ZQ01018",
    "curr_date": "Jun 12, 03:30 PM",
    "curr_time": "01:58 AM",
    "last_traded_at": "Jun 12, 03:30 PM IST",
    "bse_nse_vol": "8.91 k",
    "exc_status": "Active",
    "traded_date": "Jun 12, 2026",
    "traded_date_str": "2026 06 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/corona-remedies-10039887-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Corona Remedies Ltd Technical Momentum Shifts Amid Sideways Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-technical-momentum-shifts-amid-sideways-trend-4045994",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CoronaRemediesL_technicaldot_4045994.png",
        "date": "2026-06-11 08:05:46",
        "description": "Corona Remedies Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend, reflecting a period of consolidation after recent gains. Despite a day-on-day decline of 2.31%, the stock’s year-to-date return of 24.88% significantly outpaces the Sensex’s negative 13.19%, signalling underlying strength amid broader market weakness."
      },
      {
        "title": "Corona Remedies Ltd Upgraded to Hold by MarketsMOJO on Technical and Valuation Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/corona-remedies-ltd-upgraded-to-hold-by-marketsmojo-on-technical-and-valuation-improvements-4043576",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CoronaRemediesL_mojoScore_4043576.png",
        "date": "2026-06-10 08:36:04",
        "description": "Corona Remedies Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a shift in technical indicators alongside steady financial performance and valuation metrics. The upgrade, effective from 09 June 2026, is driven primarily by a more favourable technical trend, balanced by flat quarterly results and a high valuation, positioning the stock as a cautious but watchful opportunity for investors."
      },
      {
        "title": "Corona Remedies Ltd Shows Renewed Momentum with Technical Upgrades and Strong Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-shows-renewed-momentum-with-technical-upgrades-and-strong-returns-4043462",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CoronaRemediesL_technicaldot_4043462.png",
        "date": "2026-06-10 08:07:18",
        "description": "Corona Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by a combination of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, signalling a potential positive trajectory for the stock amid broader market challenges."
      },
      {
        "title": "Corona Remedies Ltd Downgraded to Sell Amid Technical and Financial Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/corona-remedies-ltd-downgraded-to-sell-amid-technical-and-financial-concerns-4033212",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CoronaRemediesL_mojoScore_4033212.png",
        "date": "2026-06-03 08:39:45",
        "description": "Corona Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 2 June 2026. This change reflects a combination of deteriorating technical indicators, expensive valuation metrics, and flat recent financial performance despite strong long-term fundamentals."
      },
      {
        "title": "Corona Remedies Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-technical-momentum-shifts-amid-mixed-market-signals-4033093",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CoronaRemediesL_technicaldot_4033093.png",
        "date": "2026-06-03 08:07:32",
        "description": "Corona Remedies Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend, reflecting a period of consolidation after recent gains. Despite a modest day change of 0.85%, the stock’s technical indicators reveal a nuanced picture that investors should carefully analyse amid evolving market conditions."
      },
      {
        "title": "Corona Remedies Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/corona-remedies-ltd-is-rated-hold-4024314",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/CoronaRemediesL_mojoScore_4024314.png",
        "date": "2026-05-31 10:10:18",
        "description": "Corona Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 May 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Corona Remedies Ltd Technical Momentum Shifts to Mildly Bullish Amid Hold Rating Upgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-technical-momentum-shifts-to-mildly-bullish-amid-hold-rating-upgrade-4012840",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/CoronaRemediesL_technicaldot_4012840.png",
        "date": "2026-05-26 08:07:52",
        "description": "Corona Remedies Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggesting a cautiously optimistic outlook for this pharmaceuticals and biotechnology small-cap stock."
      },
      {
        "title": "Corona Remedies Ltd Falls 5.44%: Downgrade and Technical Shift Shape Weekly Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-falls-544-downgrade-and-technical-shift-shape-weekly-decline-4007625",
        "imagepath": "",
        "date": "2026-05-23 09:01:15",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>18 May:</strong> Stock opens strong at ₹1,821.10 (+2.36%) despite Sensex decline</p>\n                    <p><strong>19 May:</strong> Downgrade to Sell announced; stock falls 2.20%</p>\n                    <p><strong>20 May:</strong> Technical momentum shifts to sideways; stock declines further by 2.81%</p>\n                    <p><strong>22 May:</strong> Week closes at ₹1,682.30, down 1.67% on the day and 5.44% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,779.10</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label..."
      },
      {
        "title": "Corona Remedies Ltd Downgraded to Sell Amid Technical and Financial Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/corona-remedies-ltd-downgraded-to-sell-amid-technical-and-financial-concerns-4000415",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/CoronaRemediesL_mojoScore_4000415.png",
        "date": "2026-05-20 08:33:57",
        "description": "Corona Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 19 May 2026. This shift reflects a combination of deteriorating technical indicators, flat recent financial performance, and valuation concerns despite the company’s strong return on capital employed and institutional investor interest."
      }
    ],
    "total": 15,
    "sid": "10039887",
    "stock_news_url": "https://www.marketsmojo.com/news/corona-remedies-10039887"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "10-Jun-2026",
      "details": "Newspaper Publication - Intimation of 22nd Annual General Meeting of the Company through Video Conferencing / Other Audio Visual Means (VC / OAVM) facility",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "10-Jun-2026",
      "details": "Intimation for Schedule of Analysts / Investor Conference",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "03-Jun-2026",
      "details": "Intimation for Non-Deal Roadshow",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Corona Remedies Ltd has declared <strong>100%</strong> dividend, ex-date: 19 Jun 26",
          "dt": "2026-06-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Corona Remedies Ltd Technical Momentum Shifts Amid Sideways Trend

2026-06-11 08:05:46

Corona Remedies Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend, reflecting a period of consolidation after recent gains. Despite a day-on-day decline of 2.31%, the stock’s year-to-date return of 24.88% significantly outpaces the Sensex’s negative 13.19%, signalling underlying strength amid broader market weakness.

Read full news article

Corona Remedies Ltd Upgraded to Hold by MarketsMOJO on Technical and Valuation Improvements

2026-06-10 08:36:04

Corona Remedies Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a shift in technical indicators alongside steady financial performance and valuation metrics. The upgrade, effective from 09 June 2026, is driven primarily by a more favourable technical trend, balanced by flat quarterly results and a high valuation, positioning the stock as a cautious but watchful opportunity for investors.

Read full news article

Corona Remedies Ltd Shows Renewed Momentum with Technical Upgrades and Strong Returns

2026-06-10 08:07:18

Corona Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by a combination of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, signalling a potential positive trajectory for the stock amid broader market challenges.

Read full news article

Corona Remedies Ltd Downgraded to Sell Amid Technical and Financial Concerns

2026-06-03 08:39:45

Corona Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 2 June 2026. This change reflects a combination of deteriorating technical indicators, expensive valuation metrics, and flat recent financial performance despite strong long-term fundamentals.

Read full news article

Corona Remedies Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-03 08:07:32

Corona Remedies Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend, reflecting a period of consolidation after recent gains. Despite a modest day change of 0.85%, the stock’s technical indicators reveal a nuanced picture that investors should carefully analyse amid evolving market conditions.

Read full news article

Corona Remedies Ltd is Rated Hold

2026-05-31 10:10:18

Corona Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 May 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Corona Remedies Ltd Technical Momentum Shifts to Mildly Bullish Amid Hold Rating Upgrade

2026-05-26 08:07:52

Corona Remedies Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggesting a cautiously optimistic outlook for this pharmaceuticals and biotechnology small-cap stock.

Read full news article

Corona Remedies Ltd Falls 5.44%: Downgrade and Technical Shift Shape Weekly Decline

2026-05-23 09:01:15

Key Events This Week

18 May: Stock opens strong at ₹1,821.10 (+2.36%) despite Sensex decline

19 May: Downgrade to Sell announced; stock falls 2.20%

20 May: Technical momentum shifts to sideways; stock declines further by 2.81%

22 May: Week closes at ₹1,682.30, down 1.67% on the day and 5.44% for the week

Week Open

Rs.1,779.10

Read full news article

Corona Remedies Ltd Downgraded to Sell Amid Technical and Financial Concerns

2026-05-20 08:33:57

Corona Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 19 May 2026. This shift reflects a combination of deteriorating technical indicators, flat recent financial performance, and valuation concerns despite the company’s strong return on capital employed and institutional investor interest.

Read full news article

View All News